Global X Genomics & Biotechnology ETF
GNOM
GNOM
61 hedge funds and large institutions have $36.4M invested in Global X Genomics & Biotechnology ETF in 2023 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 17 increasing their positions, 14 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
71% less capital invested
Capital invested by funds: $124M → $36.4M (-$87.4M)
Holders
61
Holding in Top 10
–
Calls
$1K
Puts
–
Top Buyers
| 1 | +$6.31M | |
| 2 | +$638K | |
| 3 | +$544K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$346K |
| 5 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
+$241K |
Top Sellers
| 1 | -$102M | |
| 2 | -$6.43M | |
| 3 | -$964K | |
| 4 |
EWM
Elmwood Wealth Management
Berkeley,
California
|
-$677K |
| 5 |
Lido Advisors
Los Angeles,
California
|
-$641K |